Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Equipment
Research output
Press/Media
Search by expertise, name or affiliation
Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?
Hye Lim Lee
, Hung Youl Seok
, Han Wook Ryu
, Eun Bee Cho
, Bong Chul Kim
, Byoung Joon Kim
, Ju Hong Min
, Jin Myoung Seok
, Ha Young Shin
, Sa Yoon Kang
, Oh Hyun Kwon
, Sang Soo Lee
, Jeeyoung Oh
, Eun Hee Sohn
, So Young Huh
, Joong Yang Cho
,
Jae Young Seong
,
Byung Jo Kim
*
*
Corresponding author for this work
Department of Biomedical Sciences
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aquaporin-4 (AQP4)
66%
Astrocytes
22%
Central Nervous System
11%
Central Nervous System Damage
11%
Central Nervous System Demyelinating Diseases
11%
Clinical Biomarkers
11%
Clinical Characteristics
11%
Clinical Data
11%
Clinical Serum
11%
Clinical Status
100%
Demyelinating
11%
Disease Control
11%
FAM19A5
100%
Healthy Controls
22%
Injury Marker
11%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
100%
New Biomarkers
100%
Reactive Astrocytes
11%
Reactive Gliosis
11%
Remission Period
11%
Neuroscience
Aquaporin 4 Antibody
11%
Astrocyte
33%
Central Nervous System
33%
Demyelinating Disease
11%
Gliosis
11%
Neuromyelitis Optica
100%